Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients

Digestive Diseases and Sciences

Volumn 58, Issue 5, 2013, Pages 1244-1249

  Achitei, D ^a   Ciobica, A ^b,c   Balan, G ^a   Gologan, E ^a   Stanciu, C ^c   Stefanescu, G ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

^c Octav Mayer Institute of Mathematics   (Romania)

Author keywords

Antioxidant enzymes; Inflammatory bowel diseases; Lipid peroxidation; Oxidative stress

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; ENTEROPATHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INFLAMMATORY BOWEL DISEASES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84878680749     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2510-z     Document Type: Article

References (34)

1. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. New York: Oxford University Press; 2007.
2. Scarpa M, Stylianou E. Epigenetics: concepts and relevance to IBD pathogenesis. Inflamm Bowel Dis. 2012;18:1982-1996.
3. Glocker E, Grimbacher B. Inflammatory bowel disease: is it a primary immunodeficiency?. Cell Mol Life Sci. 2012;69:41-48.
4. Harris ML, Schiller HJ, Reilly PM, et al. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease. Cause, consequence or epiphenoma ? Pharmacol Ther. 1992;53:375-408.
5. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci. 2007;52:2015-2021.
6. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
7. Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment Pharmacol Ther. 2002;16:1997-2015.
8. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:79-94.
9. Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci. 1996;41:2078-2086.
10. Koutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1433-1437.
11. Kruidenier L, Kuiper I, Van Duijn W, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol. 2003;201:17-27.
12. Durak I, Yasa MH, Bektas A, et al. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepatogastroenterology. 2000;47:1015-1017.
13. Tüzün A, Erdil A, Inal V, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. ClinBiochem. 2002;35:569-572.
14. Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci. 2008;53:2208-2214.
15. Beltrán B, Nos P, Dasí F, et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease. Inflamm Bowel Dis. 2010;16:76-86.
16. Freeman HJ. Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol. 2008;14:4127-4130.
17. Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660-1666.
18. Hritcu L, Ciobica A, Gorgan L. Nicotine-induced memory impairment by increasing brain oxidative stress. Cent Eur J Biol. 2009;4:335-342.
19. Padurariu M, Ciobica A, Dobrin I, Stefanescu C. Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics. Neurosci Lett. 2010;479:317-320.
20. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett. 2010;469:6-10.
21. Bild W, Ciobica A, Padurariu M, Bild V. The interdependence of the reactive species of oxygen, nitrogen and carbon. J Physiol Biochem. 2012;. doi: 10.1007/s13105-012-0162-2.
22. Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL. Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol Cell Physiol. 2000;278:C118-C125.
23. Hata Y, Kawabe T, Hiraishi H, et al. Antioxidant defenses of cultured colonic epithelial cells against reactive oxygen metabolites. Eur J Pharmacol. 1997;321:113-119.
24. Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol. 2007;13:187-190.
25. Akman T, Akarsu M, Akpinar H, Resmi H, Sezer E. Erythrocyte deformability and oxidative stress in inflammatory bowel disease. Dig Dis Sci. 2012;57:458-464.
26. Reimund JM, Hirth C, Koehl C, Baumann R, Duclos B. Antioxidant and immune status in active Crohn's disease: a possible relationship. Clin Nutr. 2000;19:43-48.
27. Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis. 2000;6:77-84.
28. Hinks LJ, Inwards KD, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol. 1988;41:198-201.
29. Dagli U, Balk M, Yucel D, et al. The role of reactive oxygen metabolites in ulcerative colitis. Inflamm Bowel Dis. 1997;3:260-264.
30. Tsunada S, Iwakiri R, Ootani H, Aw TY, Fujimoto K. Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol. 2003;38:1002-1003.
31. Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflam Bowel Dis. 2010;16:338-346.
32. Barbosa DS, Cecchini R, El Kadri MZ, Rodríguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty-acids. Nutrition. 2003;19:837-842.
33. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol. 2003;98:348-353.
34. Suzuki Y, Matsumoto T, Okamoto S, Hibi T. A lecithinized superoxide dismutase (PC-SOD) improves ulcerative colitis. Colorectal Dis. 2008;10:931-934.